{"id":27595,"date":"2023-03-06T09:19:00","date_gmt":"2023-03-06T08:19:00","guid":{"rendered":"https:\/\/ppr-antibioresistance.inserm.fr\/?p=27595"},"modified":"2023-03-17T09:27:10","modified_gmt":"2023-03-17T08:27:10","slug":"loms-a-publie-son-rapport-sur-les-penuries-et-la-disponibilite-des-antibiotiques-utilises-en-sante-humaine-et-veterinaire-en-france","status":"publish","type":"post","link":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/loms-a-publie-son-rapport-sur-les-penuries-et-la-disponibilite-des-antibiotiques-utilises-en-sante-humaine-et-veterinaire-en-france\/","title":{"rendered":"L\u2019OMS a\u00a0publi\u00e9 son\u00a0rapport sur les p\u00e9nuries et la disponibilit\u00e9 des antibiotiques utilis\u00e9s en sant\u00e9 humaine et v\u00e9t\u00e9rinaire en France."},"content":{"rendered":"\n<p>L\u2019<strong>Organisation Mondiale de Sant\u00e9 (OMS)\u00a0<\/strong>a publi\u00e9 son\u00a0<a href=\"https:\/\/cdn.who.int\/media\/docs\/default-source\/antimicrobial-resistance\/j0051_who_eaopa_output1_report_fr_web_v5.pdf?sfvrsn=54855661_1\" target=\"_blank\" rel=\"noreferrer noopener\">rapport sur les p\u00e9nuries et la disponibilit\u00e9 des antibiotiques utilis\u00e9s en sant\u00e9 humaine et v\u00e9t\u00e9rinaire en France<\/a>. Le rapport vise \u00e0 identifier, en France, les\u00a0<strong>causes profondes des p\u00e9nuries et du manque de disponibilit\u00e9 des antibiotiques dont le brevet est tomb\u00e9 dans le domaine public<\/strong>, dans une perspective \u00ab\u00a0Une seule sant\u00e9\u00a0\u00bb. Il comporte deux parties\u00a0: une sant\u00e9 animale et une sant\u00e9 humaine. L\u2019\u00e9dition de ce rapport s\u2019inscrit dans le cadre d\u2019un projet r\u00e9alis\u00e9 par l\u2019OMS \u00e0 la demande de la France via l\u2019instrument d\u2019appui technique (TSI) de la Direction g\u00e9n\u00e9rale d\u2019appui \u00e0 la r\u00e9forme structurelle (DG REFORM) de la Commission europ\u00e9enne.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>L\u2019Organisation Mondiale de Sant\u00e9 (OMS)\u00a0a publi\u00e9 son\u00a0rapport sur les p\u00e9nuries et la disponibilit\u00e9 des antibiotiques utilis\u00e9s en sant\u00e9 humaine et v\u00e9t\u00e9rinaire en France. Le rapport vise \u00e0 identifier, en France, les\u00a0causes profondes des p\u00e9nuries et du manque de disponibilit\u00e9 des antibiotiques dont le brevet est tomb\u00e9 dans le domaine public, dans une perspective \u00ab\u00a0Une seule [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[31,41],"tags":[],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>L\u2019OMS a\u00a0publi\u00e9 son\u00a0rapport sur les p\u00e9nuries et la disponibilit\u00e9 des antibiotiques utilis\u00e9s en sant\u00e9 humaine et v\u00e9t\u00e9rinaire en France. - Interface nationale ANTIBIOR\u00c9SISTANCE<\/title>\n<meta name=\"description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l&#039;Antibior\u00e9sistance en France et \u00e0 l&#039;international.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/loms-a-publie-son-rapport-sur-les-penuries-et-la-disponibilite-des-antibiotiques-utilises-en-sante-humaine-et-veterinaire-en-france\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"L\u2019OMS a\u00a0publi\u00e9 son\u00a0rapport sur les p\u00e9nuries et la disponibilit\u00e9 des antibiotiques utilis\u00e9s en sant\u00e9 humaine et v\u00e9t\u00e9rinaire en France. - Interface nationale ANTIBIOR\u00c9SISTANCE\" \/>\n<meta property=\"og:description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l&#039;Antibior\u00e9sistance en France et \u00e0 l&#039;international.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/loms-a-publie-son-rapport-sur-les-penuries-et-la-disponibilite-des-antibiotiques-utilises-en-sante-humaine-et-veterinaire-en-france\/\" \/>\n<meta property=\"og:site_name\" content=\"Interface nationale ANTIBIOR\u00c9SISTANCE\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-06T08:19:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-03-17T08:27:10+00:00\" \/>\n<meta name=\"author\" content=\"Emmanuel Auchet\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Emmanuel Auchet\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/loms-a-publie-son-rapport-sur-les-penuries-et-la-disponibilite-des-antibiotiques-utilises-en-sante-humaine-et-veterinaire-en-france\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/loms-a-publie-son-rapport-sur-les-penuries-et-la-disponibilite-des-antibiotiques-utilises-en-sante-humaine-et-veterinaire-en-france\/\"},\"author\":{\"name\":\"Emmanuel Auchet\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/dddace6035f5329dbab637f17f7a1ff8\"},\"headline\":\"L\u2019OMS a\u00a0publi\u00e9 son\u00a0rapport sur les p\u00e9nuries et la disponibilit\u00e9 des antibiotiques utilis\u00e9s en sant\u00e9 humaine et v\u00e9t\u00e9rinaire en France.\",\"datePublished\":\"2023-03-06T08:19:00+00:00\",\"dateModified\":\"2023-03-17T08:27:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/loms-a-publie-son-rapport-sur-les-penuries-et-la-disponibilite-des-antibiotiques-utilises-en-sante-humaine-et-veterinaire-en-france\/\"},\"wordCount\":150,\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\"},\"articleSection\":[\"Actualit\u00e9s\",\"Actualit\u00e9s PPR Antibior\u00e9sistance\"],\"inLanguage\":\"fr-FR\"},{\"@type\":[\"WebPage\",\"ItemPage\"],\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/loms-a-publie-son-rapport-sur-les-penuries-et-la-disponibilite-des-antibiotiques-utilises-en-sante-humaine-et-veterinaire-en-france\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/loms-a-publie-son-rapport-sur-les-penuries-et-la-disponibilite-des-antibiotiques-utilises-en-sante-humaine-et-veterinaire-en-france\/\",\"name\":\"L\u2019OMS a\u00a0publi\u00e9 son\u00a0rapport sur les p\u00e9nuries et la disponibilit\u00e9 des antibiotiques utilis\u00e9s en sant\u00e9 humaine et v\u00e9t\u00e9rinaire en France. - Interface nationale ANTIBIOR\u00c9SISTANCE\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website\"},\"datePublished\":\"2023-03-06T08:19:00+00:00\",\"dateModified\":\"2023-03-17T08:27:10+00:00\",\"description\":\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.\",\"breadcrumb\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/loms-a-publie-son-rapport-sur-les-penuries-et-la-disponibilite-des-antibiotiques-utilises-en-sante-humaine-et-veterinaire-en-france\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/loms-a-publie-son-rapport-sur-les-penuries-et-la-disponibilite-des-antibiotiques-utilises-en-sante-humaine-et-veterinaire-en-france\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/loms-a-publie-son-rapport-sur-les-penuries-et-la-disponibilite-des-antibiotiques-utilises-en-sante-humaine-et-veterinaire-en-france\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Infos pratiques &amp; communications\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Actualit\u00e9s\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"L\u2019OMS a\u00a0publi\u00e9 son\u00a0rapport sur les p\u00e9nuries et la disponibilit\u00e9 des antibiotiques utilis\u00e9s en sant\u00e9 humaine et v\u00e9t\u00e9rinaire en France.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\",\"name\":\"Interface nationale ANTIBIOR\u00c9SISTANCE\",\"description\":\"PPR Antibior\u00e9sistance - Inserm\",\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\",\"name\":\"Inserm\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"width\":1,\"height\":1,\"caption\":\"Inserm\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/dddace6035f5329dbab637f17f7a1ff8\",\"name\":\"Emmanuel Auchet\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"L\u2019OMS a\u00a0publi\u00e9 son\u00a0rapport sur les p\u00e9nuries et la disponibilit\u00e9 des antibiotiques utilis\u00e9s en sant\u00e9 humaine et v\u00e9t\u00e9rinaire en France. - Interface nationale ANTIBIOR\u00c9SISTANCE","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/loms-a-publie-son-rapport-sur-les-penuries-et-la-disponibilite-des-antibiotiques-utilises-en-sante-humaine-et-veterinaire-en-france\/","og_locale":"fr_FR","og_type":"article","og_title":"L\u2019OMS a\u00a0publi\u00e9 son\u00a0rapport sur les p\u00e9nuries et la disponibilit\u00e9 des antibiotiques utilis\u00e9s en sant\u00e9 humaine et v\u00e9t\u00e9rinaire en France. - Interface nationale ANTIBIOR\u00c9SISTANCE","og_description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","og_url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/loms-a-publie-son-rapport-sur-les-penuries-et-la-disponibilite-des-antibiotiques-utilises-en-sante-humaine-et-veterinaire-en-france\/","og_site_name":"Interface nationale ANTIBIOR\u00c9SISTANCE","article_published_time":"2023-03-06T08:19:00+00:00","article_modified_time":"2023-03-17T08:27:10+00:00","author":"Emmanuel Auchet","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Emmanuel Auchet","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/loms-a-publie-son-rapport-sur-les-penuries-et-la-disponibilite-des-antibiotiques-utilises-en-sante-humaine-et-veterinaire-en-france\/#article","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/loms-a-publie-son-rapport-sur-les-penuries-et-la-disponibilite-des-antibiotiques-utilises-en-sante-humaine-et-veterinaire-en-france\/"},"author":{"name":"Emmanuel Auchet","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/dddace6035f5329dbab637f17f7a1ff8"},"headline":"L\u2019OMS a\u00a0publi\u00e9 son\u00a0rapport sur les p\u00e9nuries et la disponibilit\u00e9 des antibiotiques utilis\u00e9s en sant\u00e9 humaine et v\u00e9t\u00e9rinaire en France.","datePublished":"2023-03-06T08:19:00+00:00","dateModified":"2023-03-17T08:27:10+00:00","mainEntityOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/loms-a-publie-son-rapport-sur-les-penuries-et-la-disponibilite-des-antibiotiques-utilises-en-sante-humaine-et-veterinaire-en-france\/"},"wordCount":150,"publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization"},"articleSection":["Actualit\u00e9s","Actualit\u00e9s PPR Antibior\u00e9sistance"],"inLanguage":"fr-FR"},{"@type":["WebPage","ItemPage"],"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/loms-a-publie-son-rapport-sur-les-penuries-et-la-disponibilite-des-antibiotiques-utilises-en-sante-humaine-et-veterinaire-en-france\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/loms-a-publie-son-rapport-sur-les-penuries-et-la-disponibilite-des-antibiotiques-utilises-en-sante-humaine-et-veterinaire-en-france\/","name":"L\u2019OMS a\u00a0publi\u00e9 son\u00a0rapport sur les p\u00e9nuries et la disponibilit\u00e9 des antibiotiques utilis\u00e9s en sant\u00e9 humaine et v\u00e9t\u00e9rinaire en France. - Interface nationale ANTIBIOR\u00c9SISTANCE","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website"},"datePublished":"2023-03-06T08:19:00+00:00","dateModified":"2023-03-17T08:27:10+00:00","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","breadcrumb":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/loms-a-publie-son-rapport-sur-les-penuries-et-la-disponibilite-des-antibiotiques-utilises-en-sante-humaine-et-veterinaire-en-france\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/loms-a-publie-son-rapport-sur-les-penuries-et-la-disponibilite-des-antibiotiques-utilises-en-sante-humaine-et-veterinaire-en-france\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/loms-a-publie-son-rapport-sur-les-penuries-et-la-disponibilite-des-antibiotiques-utilises-en-sante-humaine-et-veterinaire-en-france\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/"},{"@type":"ListItem","position":2,"name":"Infos pratiques &amp; communications","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/"},{"@type":"ListItem","position":3,"name":"Actualit\u00e9s","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/"},{"@type":"ListItem","position":4,"name":"L\u2019OMS a\u00a0publi\u00e9 son\u00a0rapport sur les p\u00e9nuries et la disponibilit\u00e9 des antibiotiques utilis\u00e9s en sant\u00e9 humaine et v\u00e9t\u00e9rinaire en France."}]},{"@type":"WebSite","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/","name":"Interface nationale ANTIBIOR\u00c9SISTANCE","description":"PPR Antibior\u00e9sistance - Inserm","publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization","name":"Inserm","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","width":1,"height":1,"caption":"Inserm"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/dddace6035f5329dbab637f17f7a1ff8","name":"Emmanuel Auchet"}]}},"publishpress_future_action":{"enabled":false,"date":"2026-04-13 05:46:46","action":"change-status","newStatus":"private","terms":[],"taxonomy":"category"},"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/27595"}],"collection":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/comments?post=27595"}],"version-history":[{"count":2,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/27595\/revisions"}],"predecessor-version":[{"id":27621,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/27595\/revisions\/27621"}],"wp:attachment":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/media?parent=27595"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/categories?post=27595"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/tags?post=27595"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}